🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This A Three-Part Drug-Drug Interaction Study To Evaluate Effects of Casopi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-23
Trial ID
NCT00511823
Treatments Being Tested
This study is designed to evaluate the potential pharmacokinetic interactio...
Status
Terminated
Location
GSK Investigational Site
Start Date
2005-08-10
Trial ID
NCT00334646
Treatments Being Tested
This is a two period study of healthy adult subjects to characterize the ef...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-20
Trial ID
NCT00404378
Treatments Being Tested
The purpose of the study is to evaluate how subjects with mild or moderate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09-08
Trial ID
NCT00358813
Treatments Being Tested
GW679769 may affect liver enzymes that metabolize warfarin. This study is d...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-11-01
Trial ID
NCT00404274
Treatments Being Tested
This study is being conducted to see if adding GW679769 (casopitant) to ZOF...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00326248
Treatments Being Tested
GW679769 may affect liver enzymes that metabolize dexamethasone and ondanse...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-19
Trial ID
NCT00437229
Treatments Being Tested
This study was designed is to examine the idea that GW679769 has an effect ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01
Trial ID
NCT00358410
Treatments Being Tested
This is a Phase III trial designed to demonstrate that casopitant when adde...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-11-06
Trial ID
NCT00431236
This is a Phase III trial designed to demonstrate that casopitant (GW679769...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07
Trial ID
NCT00366834